/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Nephros Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$5.35 0.0169(1.69%) NEPH at 04 Dec 2025 04:39 PM Medical Instruments & Supplies
Lowest Today 5.115
Highest Today 5.48
Today’s Open 5.42
Prev. Close 5.31
52 Week High 6.42
52 Week Low 1.39
Day’s Range: Low 5.115 High 5.48
52-Week Range: Low 1.39 High 6.42
1 day return -
1 Week return +12.0
1 month return +4.64
3 month return +33.91
6 month return +60.05
1 year return +231.9
3 year return +415.23
5 year return -12.17
10 year return -

Institutional Holdings

Wexford Capital LP 34.04

Topline Capital Management LLC 4.50

Vanguard Group Inc 3.05

Vanguard Institutional Extnd Mkt Idx Tr 1.24

Bard Associates Inc 1.24

Vanguard Total Stock Mkt Idx Inv 1.22

Geode Capital Management, LLC 0.88

Fidelity Extended Market Index 0.54

HighTower Advisors, LLC 0.53

Blair William & Co 0.34

Susquehanna International Group, LLP 0.28

Essex Investment Management Company, LLC 0.23

State Street Corp 0.15

Elkhorn Partners Limited Partnership 0.14

Mesirow Fin Investmt Mgmt Intl Equity 0.13

Fidelity Series Total Market Index 0.12

Citadel Advisors Llc 0.11

Fidelity Total Market Index 0.11

Renaissance Technologies Corp 0.10

Spartan Extended Market Index Pool F 0.09

Northern Trust Extended Eq Market Idx 0.07

NT Ext Equity Mkt Idx Fd - L 0.07

Spartan Total Market Index Pool G 0.05

State St US Extended Mkt Indx NL Cl C 0.03

DFA US Sustainability Core 1 0.03

Fidelity Nasdaq Composite Index 0.03

DFA US Core Equity 2 I 0.03

UBS Group AG 0.02

Dimensional US Core Equity 1 ETF 0.02

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.02

Morgan Stanley - Brokerage Accounts 0.02

NT Ext Eq Mkt Indx Fd DC Lend T3 0.02

SSgA U.S. Total Market Index Strategy 0.01

DFA US Core Equity Class F 0.01

Tower Research Capital LLC 0.01

Dimensional US Core Equity USD Acc 0.01

Northern Trust Wilshire 5000 0.01

Advisor Group Holdings, Inc. 0.00

Bank of America Corp 0.00

JONES FINANCIAL COMPANIES LLLP 0.00

Market Status

Strong Buy: 1

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 56.43 M

PB Ratio 5.5544

PE Ratio 37.9286

Enterprise Value 51.56 M

Total Assets 11.21 M

Volume 49231

Company Financials

Annual Revenue FY23:13542000 13.5M, FY22:9975000 10.0M, FY21:10404000 10.4M, FY20:8561000 8.6M, FY19:10334000 10.3M

Annual Profit FY23:7893000 7.9M, FY22:4731000 4.7M, FY21:5743000 5.7M, FY20:4913000 4.9M, FY19:6084000 6.1M

Annual Net worth FY23:-1839000 -1.8M, FY22:-7324000 -7.3M, FY21:-4165000 -4.2M, FY20:-4724000 -4.7M, FY19:-3179000 -3.2M

Quarterly Revenue Q3/2025:4764000 4.8M, Q2/2025:4419000 4.4M, Q1/2025:4877000 4.9M, Q3/2024:3518000 3.5M, Q2/2024:3252000 3.3M

Quarterly Profit Q3/2025:2915000 2.9M, Q2/2025:2795000 2.8M, Q1/2025:3154000 3.2M, Q3/2024:2149000 2.1M, Q2/2024:1878000 1.9M

Quarterly Net worth Q3/2025:337000 0.3M, Q2/2025:237000 0.2M, Q1/2025:558000 0.6M, Q3/2024:183000 0.2M, Q2/2024:-289000 -0.3M

Fund house & investment objective

Company Information Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. It also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, bacteria, cysts, particulates, heavy metals, chemical compounds, scale build-up in downstream equipment, and other various contaminants. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Organisation Medical Instruments & Supplies

Employees 31

Industry Medical Instruments & Supplies

CEO Mr. Robert Banks

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow